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Abstract The disruption of the extracellular disc matrix is
a major hallmark of disc degeneration. This has previously
been shown to be associated with an up-regulation of major
matrix metalloproteinase (MMP) expression and activity.
However, until now hardly any data are available for MMP/
TIMP regulation and thereby no concept exists as to which
MMP/TIMP plays a major role in disc degeneration. The
objective of this study was, therefore, to identify and quan-
tify the putative up-regulation of MMPs/TIMPs on the
mRNA and protein level and their activity in disc material in
relation to clinical data and histological evidence for disc
degeneration. A quantitative molecular analysis of the
mRNA expression levels for the MMPs (MMPs-1, -2, -3, -7,
-8, -9, -13) and the MMP inhibitors (TIMPs-1 and -2) was
performed on 37 disc specimens obtained from symptomatic
disc herniation or degeneration. In addition, disc specimens
from patients without disc degeneration/herniation (=con-
trols) were analyzed. Expression of MMPs-1, -2, -3, -7, -8,
-9, -13 and TIMPs-1, -2 was analyzed using quantitative RT-
PCR, normalized to the expression level of a house keeping
gene (GAPDH). Gene expression patterns were correlated
with MMP activity (in situ zymography), protein expression
patterns (immunohistochemistry), degeneration score (rou-
tine histology) and clinical data. MMP-3 mRNA levels were
consistently and substantially up-regulated in samples with
histological evidence for disc degeneration. A similar but
less pronounced up-regulation was observed for MMP-8.
This up-regulation was paralleled by the expression of
TIMP-1 and to a lesser extent TIMP-2. In general, these
findings could be confirmed with regard to protein expres-
sion and enzyme activity. This study provides data on the
gene and protein level, which highlights the key role of
MMP-3 in the degenerative cascade leading to symptomatic
disc degeneration and herniation. Control of the proteolytic
activity of MMP-3 may, therefore, come into the focus when
aiming to develop new treatment options for early disc
degeneration.
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Introduction
The intervertebral disc is composed of a dense connective
tissue which can be divided into the fibrocartilaginous
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annulus fibrosus and the more gelatinous nucleus pulposus.
The motion segment thereby functions as a shock absorber
and resists tensile and torsion forces. The matrix is mainly
made up of collagen fibers that are responsible for the
tissue tension while intermingled proteoglycans provide
flexibility and hydrate the disc. Recent systematic histo-
morphological analysis provided circumstantial evidence
that a disruption of the disc matrix occurs in the young
adult age and that this is closely and significantly associ-
ated with age-related disc degeneration [5]. The occurrence
of major clefts and tears are hallmarks of the degenerative
cascade, which finally lead to a loss of extracellular disc
matrix. These features have been shown to be linked to the
expression and activity of major matrix metalloproteinases
(MMPs) [16, 31, 36].
MMPs are a family of proteolytic enzymes that parti-
cipate in the degradation of all major matrix components,
including glycoproteins, proteoglycans and especially col-
lagen. Under normal physiological conditions, the effi-
ciency of these enzymes is regulated by their own
activation mechanism as well as by endogenous tissue
inhibitors of metalloproteinases (TIMP-1, -2, -3). In vari-
ous pathological processes, however, a dysbalance between
MMPs and TIMPs plays a pivotal role in tissue degradation
and decomposition [3]. According to their substrate spec-
ificity and gene structure, the vast number of MMPs (up to
now *24 members) can be classified into six groups: the
collagenases (MMP-1, -8, -13, and -18) are the only
proteases that cleave native interstitial collagen. The gel-
atinases (MMP-2, and -9) digest denatured collagens and
non-helical collagen in basement membranes, while the
stromelysins (MMP-3, and -10) and matrilysins (MMP-7
and -26) mainly degrade the protein core of proteoglycans
and small non-collagenous proteins. The membrane-type
MMPs (MT-MMPs or MMP-14, -15, -16 and -17) and the
so-called ‘‘minor MMPs’’ (e.g. enamelysin MMP-20 and
epilysin MMP-28) have specific roles either in the activa-
tion of various proteases at the cell membrane (MT-MMPs)
or in the organ-specific developmental processes (e.g.
enamelysin MMP-20 at the dental development) [19, 34].
Recent studies have shown that particularly MMP-1, -2
and -3 are increasingly expressed in degenerated disc tissue
samples as evidenced by biochemistry, immunohisto-
chemistry (protein), in situ hybridization (mRNA expres-
sion) and enhanced enzymatic, gelatinolytic activity (in
situ zymography) [1, 8, 9, 15, 18, 22, 29, 31, 33, 36].
Despite these preliminary data, it remains unclear which
member(s) of the MMP family are mainly responsible for
the matrix disruption and decomposition. Furthermore, the
role of the endogenous MMP inhibitors, the TIMPs, is also
widely unknown and first reports ascribe them an important
function in the pathological misregulation of the proteo-
lytic activity [16]. Although immunohistochemical
techniques provide excellent data on tissue localizations,
they do not allow a quantification of these processes.
In the present study, various MMPs/TIMPs were ana-
lyzed on the gene/protein level as well as with regard to
their activity and data was correlated with morphological
and clinical data. The aim of this study was to identify
enzymes and their inhibitors that are involved in disc
destruction, using a broad methodological spectrum and an
extensive set of specimens from both degenerated/herni-
ated and normal discs.
Materials and methods
Study population
This study was performed on a series of well-defined fresh
surgical specimens to prevent the well-known rapid degra-
dation of mRNA. The study group comprised of 37 lumbar
specimens obtained during surgical procedures, i.e. lumbar
discectomies and interbody fusions. In addition, we were able
to obtain fresh lumbar disc tissue samples from two young,
previously healthy adults (22 and 28 years old) with poly-
trauma and fracture of the vertebral bodies where the discs
were removed during surgical stabilization procedures (con-
trols). Both samples neither showed gross morphological
alterations nor enhanced histological degeneration signs. In
the patient group, it was recorded whether the disc specimen
was obtained from a disc exhibiting a protrusion (contained)
or whether it was an extruded or sequestrated disc (non-con-
tained). The average age of the 21 females and 16 males in the
study group was 53.8 years (range 29–89 years). All patients
underwent surgery for disc protrusion, herniation or degene-
rative disc disease. The distribution of the samples across the
disc levels was as follows: L2/3 (n = 6), L3/4 (n = 5), L4/5
(n = 15), L5/S1 (n = 11). Clinical data on low back pain
history, related disability and imaging findings (radiographs,
MRI) were available for all cases (Table 1).
Tissue preparation
After removal of the specimen, the material was immedi-
ately dissected into three parts:
1. The first portion of the specimen was immediately
immersed in RNA-later solution (Qiagen, Hilden,
Germany) in order to ensure its conservation within
less than 15 min after removal.
2. The second portion was immediately fixed in 3.7%
buffered formaldehyde (pH 7.4). Following routine
fixation, this material was embedded in paraffin for the
preparation of thin sections (2–4 lm), which were
placed on silanized glass slides for routine and
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histochemical stainings (H&E, Elastica-van Gieson’s
connective tissue stain, Alcian blue-PAS, Masson-
Goldner) as well as immunohistochemical analysis as
previously described [5].
3. The third portion of the material was immediately deep
frozen at –80C for the preparation of in situ zymo-
graphy on freshly frozen sections.
RNA extraction and cDNA synthesis
From the tissue samples that had been fixed in RNA-later
solution (1st portion of the material), total RNA was
extracted using the RNeasy Protect Midi Kit (Qiagen,
Hilden, Germany) according to the recommendations of the
manufacturer. The tissue was homogenized in a mechanical
Table 1 Clinical and histological characterization of the study population
# Age Sex Level Disc pathology Imaging Pain duration
(weeks)
HDSa
1 56 Female L4/5 Contained Disc degeneration 9 7
2 54 Female L2/3 Contained Disc degeneration 20 11
3 33 Male L4/5 Non-contained Sequestration 6 12
4 30 Female L5/S1 Non-contained Extrusion 1 8
5 70 Female L4/5 Non-contained Extrusion 10 10
6 54 Male L4/5 Contained Disc degeneration 8 9
7 37 Female L4/5 Non-contained Extrusion 20 10
8 39 Male L4/5 Non-contained Extrusion 14 12
9 29 Female L3/4 Non-contained Sequestration 14 10
10 47 Female L5/S1 Contained Disc degeneration 30 11
11 36 Male L5/S1 Contained Disc degeneration 22 11
12 45 Male L5/S1 Non-contained Extrusion 5 8
13 45 Female L5/S1 Non-contained Extrusion 15 10
14 35 Male L3/4 Contained Protrusion 9 11
15 40 Female L4/5 Contained Disc degeneration 2 7
16 49 Female L5/S1 Contained Disc degeneration 16 10
17 65 Male L4/5 Contained Disc degeneration 20 11
18 48 Female L4/5 Non-contained Extrusion 5 9
19 89 Female L5/S1 Non-contained Extrusion 6 9
20 70 Male L3/4 Non-contained Extrusion 20 11
21 49 Female L5/S1 Contained Disc degeneration 3 7
22 58 Female L5/S1 Non-contained Extrusion 2 6
23 67 Female L2/3 Non-contained Sequestration 5 8
24 39 Female L4/5 Non-contained Extrusion 4 9
25 65 Female L5/S1 Non-contained Sequestration 4 7
26 69 Male L4/5 Contained Disc degeneration 8 11
27 50 Male L3/4 Contained Disc degeneration 4 9
28 77 Male L2/3 Non-contained Sequestration 23 12
29 63 Male L4/5 Non-contained Extrusion 26 13
30 62 Male L3/4 Contained Disc degeneration 4 8
31 58 Female L5/S1 Non-contained Extrusion 3 13
32 73 Female L5/S1 Non-contained Sequestration 7 9
33 66 Male L2/3 Non-contained Sequestration 15 11
34 48 Female L4/5 Contained Disc degeneration 21 10
35 65 Female L4/5 Non-contained Sequestration 18 10
36 71 Male L2/3 Contained Disc degeneration 8 8
37 59 Male L3/4 Contained Protrusion 5 6
a HDS modified according to Boos et al. [5]
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homogenizer (Ultraturrax, IKA, Staufen, Germany). The
resulting tissue homogenate was centrifuged and the
remaining pellet was digested with Proteinase K (10 lg/ml,
15 min, room temp.; Qiagen, Hilden, Germany) before
being applied to a RNeasy Midi column together with the
supernatant from the centrifugation step. Following
extraction, the RNA was quantified photometrically and
cDNA was synthesized from equal concentrations of each
RNA preparation using oligo dT primers provided in the
cDNA Synthesis Kit (First Strand cDNA Synthesis Kit,
Pharmacia Biotech, Freiburg, Germany) following the
manufacturer’s instructions.
Real-time quantitative RT-PCR
Quantitative RT-PCR was performed on a Light-Cycler
(Roche, Mannheim, Germany) using specific primers in
combination with the Light-Cycler FastStart Master Sybr-
Green I (Roche). The Light Cycler-Primer Sets for MMP-1,
-2, -3, -7, -8, -13 and that of tissue inhibitors (TIMPs) TIMP-
1 and -2 target genes as well as for a series of housekeeping
genes were purchased from Search LC (Heidelberg, Ger-
many). PCR conditions were set according to the manufac-
turer’s instructions provided with the primer sets.
Prior to the quantification of the target genes, an appro-
priate house keeping gene had to be determined. Since
previous studies had shown differences between various
parameters [2], we performed a pre-test by comparative
analysis of various usually applied genes, such as b-actin,
HPRT, cyclophillin B, PBGD, glucose-6-phosphate (G6P)
and GAPDH. Out of those six genes that are usually used as
house keeping genes, b-actin, HPRT, cyclophillin B, PBGD
and G6P revealed differences between various samples
which are consistent with previous observations on cell
cultures of tumor cells [2]. Due to the extensive testing on
disc tissue, GAPDH proved to be the most constant and
replicable parameter so that this housekeeping gene was
selected for all subsequent experiments. Technical details
have previously been reported [2].
For calculation of the MMP/TIMP target gene expres-
sions, the number of transcripts obtained by quantitative
RT-PCR was divided by the number of GAPDH house-
keeping gene transcripts. In this manner, target gene
expressions for all IVD samples were normalized giving
transcription level results that could be compared with each
other. All amplification reactions were performed in trip-
licate. Mean and standard deviation were calculated.
Immunohistochemistry
The immunostainings were essentially performed as
described previously in detail [12, 15–17]. For the locali-
zation of MMPs-1, -2, -3 and -9, we used specific
polyclonal antibodies (MMP-1, Alexis, Switzerland;
MMP-2, -3, -9, BioVision, CA, USA). Briefly, pretreated
deparaffinized slides were incubated with the specific pri-
mary antibody. Following washing steps, a secondary
antibody system coupled with the avidin–biotin complex
(Vector, Burlingame, USA) was used in order to localize
the antigen. As a chromogenic substrate, we used diam-
inobenzidine (DAKO, Hamburg, Germany).
Control sections using either non-specific immuno-
globulins of comparable concentration (‘‘isotype control’’)
or after omission of the specific primary antibody (‘‘blank
control’’) were run in parallel.
In situ zymography
In situ zymography was performed as an internal control
for the biological activity of the enzymes under investi-
gation. We localized the gelatinolytic activity in tissue
sections of fresh disc samples. This technique was applied
as previously described [36] which is a slight modification
of the in situ zymography method used widely in onco-
logy [20, 21, 26]. Briefly, standardized, 5-lm-thick frozen
sections of the fresh material were placed on 1.5% gela-
tine films (which contain 12% polyacrylamide for the
polymerization of the gel) and incubated in a wet cham-
ber for 16 h. Subsequently, the slides were stained with
Poinceau red (Merck, Darmstadt, Germany) as previously
described [36] thereby avoiding over-staining effects. The
loss of staining was scored by two independent observers
with respect to the histological tissue alterations in a
semi-quantitative manner. Since the gelatine films dif-
fered slightly in thickness, the bleaching of the sample
area was normalized to the gelatine staining surrounding
the sample-layered area. Similarly, any slight differences
in the thickness of the sections were also normalized with
respect to the surrounding staining intensity. Thereby,
mainly the gelatinolytic activity of MMPs is detected, i.e.
the activity of MMP-2 and -9 is monitored. However,
recently [2] it has been shown that high activity levels of
stromelysins (MMP-3, -10, -11) can also induce gelatine
degradation.
Evaluation and statistical analysis
All slides of the routine stainings were first subjected to a
qualitative examination to determine the histological
degeneration score (HDS) as previously described [5]. The
observations were classified as following: cell proliferation
(clustering of chondrocytes), tear and cleft formation,
granular matrix changes and mucoid degeneration of the
ground substance. Cell death was omitted from the scoring
because it was often difficult to reliably assess this
parameter in the surgical specimens. A distinction was
1576 Eur Spine J (2009) 18:1573–1586
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made between annular and nuclear disc tissue on the basis
of histo-morphological criteria, especially density and
arrangement of the collagen network, which was evaluated
under polarized light, as previously described [5].
For analysis of gene expression results, we first com-
pared the absolute values, but also evaluated the level of
amplification using five levels: none (no amplification or
minimal amplification, maximum 4-fold base line level);
minor (5–50-fold base line level), moderate (50–500-fold
base line level), strong (500–5,000 100-fold amplification
levels) and very strong ([5,000-fold base line level) each
compared to the housekeeping gene level. The immuno-
histochemical stainings were evaluated morphometrically
on a semi-quantitative approach. The mean number of
stained cells per 100 cells was evaluated in nuclear and
annular regions as done in previous studies [24, 25]. The in
situ zymographic slides were evaluated semi-quantitatively
with respect to the extent of the gelatinolytic activity.
Therefore, the reduction of gelatine staining in comparison
to the surrounding background staining of the gelatine film
was semi-quantitatively scored as 0 = none, 1 = minor,
2 = intermediate, 3 = major.
The correlation of mRNA levels and clinical/morpho-
logical data was explored with a Spearman’s rank corre-
lation test. Similarly, the inter-correlation of the MMPs and
TIMPs was investigated with a Spearman test. The level of
statistical significance was set at 0.05, two-tailed.
Results
Histological observations and determination
of the HDS
The histo-morphological appearance of the material was
almost identical to that described in previous studies on
surgical material [5, 36]. Accordingly, both the qualitative
extent of changes (chondrocyte proliferation, cleft forma-
tion, granular changes, mucoid matrix degeneration) and
the ranking of the extent of those alterations provided very
similar results as seen in previous comparable cases
(Table 1) [5]. The present study material was assumed to
be representative with respect to the histopathological
changes for age-related disc degeneration. Furthermore, no
significant difference was noted between disc tissue sam-
ples with and without herniation in terms of degeneration
grade.
Gene expression
In this analysis, mRNA levels were determined by nor-
malizing the transcripts of the MMP and TIMP target genes
by the housekeeping gene GAPDH which had proven to
provide a constant expression level in experimental settings
as previously described [2].
The assessments on the two samples from previously
asymptomatic trauma patients (controls) showed in both
cases either no detectable or very low levels of MMP gene
expression ranging for all MMPs tested between 0- and 4-
fold increase when compared to GAPDH, suggesting an
either absent or minimal expression of all MMPs. Based on
this data, our threshold for non-increased mRNA levels
was set at 5-fold.
In symptomatic patients, large variations in gene
expression were observed related to the individuals and
MMPs. None of the investigated MMPs and TIMPs
exhibited a correlation to the type of pathology, i.e. disc
degeneration without herniation, disc protrusion, disc
extrusion or sequestration. Similarly, no statistical signifi-
cant difference was observed when comparing contained
and non-contained disc herniations (Table 2).
Stromelysins (MMP-3)
All but one case showed increased MMP-3 (previously
termed stromelysin-1) levels, with the strongest increase in
mRNA expression (Fig. 1) compared to all other MMPs
analyzed (up to approx. 50,000-fold increase, mean 7429).
The expression of MMP-3 was more elevated in males than
females (rho = 0.363, p = 0.027) and in patients with a
longer duration of the current pain episode (rho = 0.444,
p = 0.006). In addition, MMP-3 showed the strongest
correlation (rho = 0.6, p \ 0.001) to histo-morphological
matrix alterations (Fig. 2; Table 2).
Matrilysins (MMP-7)
Gene expression levels of MMP-7 were elevated in 15 out
of 37 samples (mean 58). Even though the substrate
specificity of MMP-7 and MMP-3 is very similar, we could
not detect a significant correlation between their expression
levels. In contrast to MMP-3, MMP-7 did not exhibit any
correlation to histo-morphological matrix alterations or
clinical findings (Fig. 1; Table 2).
Collagenases (MMP-1, -8, -13)
Although MMP-1, -8 and-13 all belong to the same family
of MMPs, i.e. collagenases, they did not show a compa-
rable pattern and correlations could only be observed
between some of the family members. However, no sig-
nificant correlation was observed with regard to the disc
pathology, i.e. disc sequester, contained/non-contained
disc. Gene expression of MMP-1 (previously termed
‘‘interstitial collagenase’’) was minorly or moderately
Eur Spine J (2009) 18:1573–1586 1577
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Table 2 Correlation matrix of clinical and morphological findings with mRNA expression levels of MMPs and TIMPs
Variable MMP-1 MMP-2 MMP-3 MMP-7 MMP-8 MMP-9 MMP-13 TIMP-1 TIMP-2
Sex
rho –0.291 –0.176 0.363* –0.148 –0.222 0.054 –0.224 –0.460** –0.357*
sig. 0.081 0.297 0.027 0.382 0.186 0.752 0.183 0.004 0.030
Age
rho 0.118 0.078 –0.147 –0.043 –0.077 0.207 0.059 0.071 –0.160
sig. 0.488 0.647 0.386 0.800 0.650 0.219 0.731 0.676 0.345
Pain duration
rho –0.124 –0.112 0.444** 0.251 0.325* –0.051 –0.010 –0.127 –0.036
sig. 0.465 0.510 0.006 0.134 0.050 0.764 0.953 0.455 0.832
Disc pathology
rho –0.049 –0.074 –0.050 0.031 –0.037 0.101 –0.052 0.003 –0.166
sig. 0.772 0.663 0.770 0.857 0.829 0.552 0.761 0.986 0.326
Disc level
rho 0.097 –0.045 –0.232 0.244 0.018 –0.054 –0.050 0.089 0.029
sig. 0.568 0.791 0.167 0.146 0.918 0.753 0.770 0.601 0.864
HDS score
rho –0.187 –0.100 0.600** 0.123 0.342* 0.040 –0.199 –0.036 0.014
sig. 0.267 0.554 0.0001 0.469 0.039 0.815 0.238 0.832 0.936
Cell proliferation
rho –0.006 0.092 0.464** 0.059 0.141 –0.041 –0.156 –0.045 –0.136
sig. 0.970 0.589 0.004 0.729 0.405 0.811 0.356 0.789 0.422
Tears/clefts
rho –0.041 –0.071 0.365* 0.130 0.356* –0.029 –0.108 0.096 –0.001
sig. 0.810 0.675 0.026 0.442 0.031 0.867 0.524 0.570 0.996
Granular changes
rho –0.249 –0.090 0.292 –0.045 0.147 –0.011 –0.188 0.001 0.138
sig. 0.137 0.597 0.080 0.790 0.385 0.947 0.265 0.996 0.414
Mucoid degeneration
rho –0.041 –0.164 0.454** 0.281 0.318 0.071 0.052 –0.086 –0.063
sig. 0.809 0.332 0.005 0.092 0.055 0.678 0.761 0.612 0.709
MMP-1
rho 1.000 0.716** –0.178 0.265 –0.319 0.184 0.686** 0.393* 0.439**
sig. 0.0001 0.291 0.113 0.054 0.274 0.0001 0.016 0.006
MMP-2
rho 0.716** 1.000 0.047 0.144 –0.336* 0.178 0.562** 0.359* 0.321
sig. 0.0001 0.781 0.396 0.042 0.291 0.0001 0.029 0.052
MMP-3
rho –0.178 0.047 1.000 0.074 0.242 0.184 0.146 –0.281 –0.237
sig. 0.291 0.781 0.662 0.149 0.276 0.389 0.092 0.158
MMP-7
rho 0.265 0.144 0.074 1.000 0.106 –0.038 0.279 0.193 0.162
sig. 0.113 0.396 0.662 0.534 0.821 0.095 0.253 0.338
MMP-8
rho –0.319 –0.336* 0.242 0.106 1.000 0.141 –0.328* –0.018 0.033
sig. 0.054 0.042 0.149 0.534 0.405 0.047 0.916 0.846
MMP-9
rho 0.184 0.178 0.184 –0.038 0.141 1.000 0.336* –0.100 –0.114
sig. 0.274 0.291 0.276 0.821 0.405 0.042 0.556 0.502
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enhanced in 12 cases and strongly enhanced in 2 cases
(mean 56) (Fig. 3). Expression levels of MMP-1 strongly
correlated with MMP-13 (rho = 0.686, p \ 0.0001), but
not with MMP-8 (Table 2). In contrast, levels for MMP-8
increased minorly in 18 and moderately in 10 cases and
strongly in 6 cases (overall mean 261) (Fig. 3) and showed
a positive correlation to the pain duration (rho = 0.325,
p \ 0.05) and histo-morphological degeneration
(rho = 0.342, p = 0.039) (Fig. 4). MMP-8 was not corre-
lated with MMP-1, but we found an inverse correlation
with MMP-13 levels (rho = –0.328, p = 0.047).
Gelatinases (MMP-2, -9)
In all investigated IVD tissue samples, gelatinase mRNA
levels were generally lower compared to collagenase
mRNA levels. There was neither a significant correlation
between MMP-2 and MMP-9 nor with clinical parameters
or histo-morphological parameters. MMP-2 expression
exerted a minor or moderate increase in 14 cases and a
strong increase in 3 cases (mean 80) (Fig. 5). MMP-2
correlated with all collagenases, especially with MMP-1
(rho = 0.716, p \ 0.0001) and MMP-13 (rho = 0.562,
p \ 0.0001) and to a lesser extent and inversely with
MMP-8 (rho = –0.336, p = 0.042) (Table 2).
Tissue inhibitors of MMPs (TIMP-1, -2)
Besides the analysis of major MMPs, we analyzed the
expression levels for the two most important endogenous
MMP inhibitors, TIMP-1 and -2. We observed a hetero-
geneous expression pattern of the two inhibitors with lower
levels of TIMP-2 in the majority of the IVD specimen.
TIMP-1 mRNA levels were enhanced in all but two
specimens, with a moderate increase in 9 cases, a strong
increase in 21 cases and a very strong increase in 3 cases
(mean 2726) (Fig. 6). TIMP-1 positively correlated with
MMP-1 expression levels (rho = 393, p = 0.016). For
TIMP-2, a moderate increase was noted in 16 cases and a
strong increase in 6 cases (120- and 2,400-fold increase,
mean 135). TIMP-2 also showed a positive correlation to
MMP-1, similar to TIMP-1 (rho = 0.439, p = 0.006). For
both inhibitors, no correlation with type and level of disc
pathology or histo-morphological parameters could be
detected.
Immunohistochemistry
In order to investigate protein levels, we additionally per-
formed an immunohistochemical analysis of the formalin-
fixed and paraffin-embedded material. Due to limited
Table 2 continued
Variable MMP-1 MMP-2 MMP-3 MMP-7 MMP-8 MMP-9 MMP-13 TIMP-1 TIMP-2
MMP-13
rho 0.686** 0.562** 0.146 0.279 –0.328* 0.336* 1.000 0.205 0.263
sig. 0.0001 0.0001 0.389 0.095 0.047 0.042 0.223 0.116
TIMP-1
rho 0.393* 0.359* –0.281 0.193 –0.018 –0.100 0.205 1.000 0.482**
sig. 0.016 0.029 0.092 0.253 0.916 0.556 0.223 0.003
TIMP-2
rho 0.439** 0.321 –0.237 0.162 0.033 –0.114 0.263 0.482** 1.000
sig. 0.006 0.052 0.158 0.338 0.846 0.502 0.116 0.003
* Correlation is significant at the 0.05 level (two-tailed)
** Correlation is significant at the 0.01 level (two-tailed)
MMP-3 MMP-7
none
minor 
moderate 
strong 
very strong
none
minor 
moderate 
strong 
very strong
A B
Fig. 1 Expression profile of MMP-3 and MMP-7. Pie charts
representing the amount of cases with an increase of RNA levels
for MMP-3 (a) and MMP-7 (b) compared to the housekeeping gene.
A 50-fold increase was termed minor, up to 500-fold moderate, up to
5,000-fold strong and more than 5,000-fold very strong
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amount of material, we focused on MMP-1, -2, -3 and -9.
All enzymes could be detected, with highest values for
MMP-3 (mean 65%, range 15–85%, positive cells)
(Fig. 7a), supporting the data obtained by gene expression.
MMP-1 was also detectable (mean 55%, range 10–65%,
positive cells) (Fig. 7b), while nuclear staining of MMP-2
and -9 was less pronounced (MMP-2: mean 20%, range
0–40%; MMP-9: mean 10%, range 0–30%, positive cells).
There was mainly but not exclusively a positive staining
for the MMPs in those areas with tissue disruption
(clefting). There was no statistical significant association
between the number of labeled cells, mRNAs expression
levels (MMPs) and in situ zymography results.
In situ zymography
Out of the 37 samples with molecular analysis, 24 samples
were available with sufficient and representative material
for in situ zymography. In eight cases, either no material
was available for this analysis or the material was too
Fig. 2 Correlation of MMP-3 with histo-morphologic alterations.
Histo-morphologic age-related alterations of the disc indicated by cell
proliferation (a), tears and clefts formation (b), and mucoid degen-
eration (c) exhibited a significant correlation to the increase in mRNA
expression for MMP-3. This was also reflected in the overall
histologic degeneration score (d). Error bars represent standard error
of the mean
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Fig. 3 Expression profile of collagenases MMP-1, MMP-8 and
MMP-13. Pie charts representing the amount of cases with an
increase of RNA level for MMP-1 (a), MMP-1 (b) and MMP-13 (c)
compared to the housekeeping gene. A 50-fold increase was termed
minor, up to 500-fold moderate, up to 5,000-fold strong and more
than 5,000-fold very strong
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small/restricted. In five cases, the material was not repre-
sentative for the material for molecular analysis. In 18 of
the 24 evaluated samples, an intermediate to major gela-
tinolytic activity was seen, while the other 6 cases did only
show minor gelatinolysis (Fig. 8a). No direct correlation
was seen with regard to the expression levels of the gela-
tinases. Enzyme activity was mainly seen in areas of the
nucleus pulposus, but less frequently annular regions were
affected. All disc samples with major histological signs
of disc degeneration, in particular with tear and cleft
formation, revealed enhanced proteolytic activity as
determined by in situ zymography (Fig. 8b). There was an
obvious association of gelatinolytic activity and cleft
formation.
Discussion
Low back pain is one of the most frequent causes for
work failure in Western industrial countries. Despite this
Fig. 4 Correlation of MMP 8 with pain duration and histo-morpho-
logic alterations. Pain duration (a) and histo-morphologic age-related
alterations (HDS) (b) exhibited a significant correlation to the
increase in mRNA expression for MMP-8. Error bars represent
standard error of the mean
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Fig. 5 Expression profile of gelatinases MMP-2 and MMP-9. Pie
charts representing the amount of case with an increase of RNA level
for MMP-2 (a) and MMP-9 (b) compared to the housekeeping gene.
A 50-fold increase was termed minor, up to 500-fold moderate, up to
5,000-fold strong and more than 5,000-fold very strong
TIMP-1 TIMP-2
none
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strong 
very strong
none
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Fig. 6 Expression profile of TIMP-1 and TIMP-2. Pie representing
the amount of cases with an increase of RNA level for TIMP-1 (a)
and TIMP-2 (b) compared to the housekeeping gene. A 50-fold
increase was termed minor, up to 500-fold moderate, up to 5,000-fold
strong and more than 5,000-fold very strong
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enormous socio-economic burden, the causes for disc
degeneration are still poorly understood, especially with
regard to the molecular events that are involved. In parti-
cular, the processes that lead to the destruction and resorption
of extracellular disc matrix are unclear. Recently, extensive
analyses have been undertaken to fill the above-mentioned
knowledge gap. An increasing puzzle of data on distinct
molecular changes has been described during disc degene-
ration. This puzzle comprises of enhanced apoptosis of
annular disc cells [30], occurrence of phagocytic phenotypic
disc cell changes [25], up-regulation of various cytokines,
such as TNF-a [35] and TGF-b [23], significant changes of
extracellular matrix composition [24, 32] and significantly
altered expression and activity of MMPs [16, 31, 36]. The
latter have recently been postulated to play a pivotal role in
destruction and resorption of the degenerating disc [36].
The MMPs are a group of at least 24 different enzymes
that are unique in their capability to cleave various
Fig. 7 Immunohistochemical
detection of MMP-1 and MMP-
3. a Immunostaining for MMP-
3 at a cleft margin with
numerous positively labeled
cells (red staining, case #28).
b Several nuclear cells are also
positive for MMP-1 (red
staining, case #5)
Fig. 8 In situ zymography of
intervertebral disc samples. a
Section through a disc sample
with minimal gelatinolytic
activity with mostly preserved
gelatin matrix (red staining,
Score 1, case #22). b Extensive
gelatinolytic activity (HDS 10,
case #5) with loss of the red-
stained gelatin matrix substrate
(asterisk). Note focal clefts
along the lightly stained activity
areas (arrows)
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extracellular matrix constituents. MMP enzyme activity is
controlled by endogenous inhibitors, the ‘‘tissue inhibitors
of metalloproteinases’’ (TIMPs), which comprise four
members. TIMP-1 and -2 are the two most important and
widespread proteins involved in human MMP regulation.
TIMP-3 and -4 are found in various tissues, but seem to be
of minor clinical significance. Although recent research
activities started to put an emphasis on elucidating the role
as well as the interplay of MMPs and TIMPs, studies up to
now used single detection methods or small sample sizes;
in addition, samples were mostly taken from patients with
degenerative disc disease, but no comparison to healthy
tissue was sought [16, 31, 36]. Therefore, the aim was to
perform a comprehensive study on the role and the inter-
play of MMPs and TIMPs with regard to mRNA levels,
protein levels and enzyme activity, using not only discs
from patients with disc disease, but also putative healthy
discs.
Recent studies used immunolocalization, in situ
hybridization and in situ zymography for the study of
MMP/TIMP localization, synthesis and activation in disc
tissue samples [16, 31, 36]. These studies provided con-
siderable insight into the role of the MMP/TIMPs in discs:
• Major MMPs are expressed in enhanced amounts in
disc tissue with signs of disc degeneration.
• MMPs are synthesized by local cells.
• Synthesis seems to be up-regulated in discs with
degenerative lesions.
• Enzymatic activity as evidenced by gelatinolytic acti-
vity is mostly seen in areas of tissue destruction (such
as cleft and tear formation).
• TIMPs are synthesized in parallel with major MMPs.
• The amount of TIMPs synthesized seems to be up-
regulated in correlation to disc tissue degeneration.
Despite some recent investigations by Le Maitre et al.
[16], it still remains largely unclear whether TIMP
expression really parallels expression of major MMPs or
whether it is lower or higher than the MMP levels. Fur-
thermore, the role of the various individual MMPs remains
unclear, since morphological techniques provide no—or at
best only partially—quantitative data on the MMP changes.
In contrast, biochemical analytical techniques, such as gel
zymography, provide semi-quantitative data on distinct
MMPs; however, they do not allow insight into the regional
distribution of the enzymes [6]. In order to overcome these
drawbacks, we designed this study that uses a combination
of morphology and quantitative analytical procedures.
Since tissue samples for both analyses should be small to
avoid tissue bias due to substantial tissue heterogeneity [1],
we chose the quantitative RT-PCR technique.
Up to now, quantitative PCR has mainly been applied to
experimental settings, such as animal models of disc
degeneration [1, 10, 17, 28, 33, 37]. In summary, these
models provide clear evidence that either acute or more
protracted lesion of annular and/or nuclear disc tissue leads
to an initial up-regulation of major MMPs, such as MMP-3
[18], MMP-13 [17, 28] and MMPs-1 and -9 [1]. In contrast,
several other studies showed unchanged or even slightly
decreased expression levels for MMPs, such as MMP-1
[37] in particular experimental settings, such as under high
pressure (30 atm cyclic pressure). In general, the changes
in the experimental studies could be related to pre-opera-
tive baseline expression levels and the changes differed
between 2- and 8-fold.
In contrast, only very few studies cover the determina-
tion of mRNA levels for different MMPs in human tissue
samples. Very recently, Bertram et al. [4] studied scoliotic
disc samples for the expression of several MMPs (MMP-3,
-13 and -17) along with various anabolic tissue markers. No
differences were seen in the expression levels between
scoliotic tissue samples and non-scoliotic control discs from
trauma operation specimens. However, no analysis was
made with regard to age-related degeneration of different
extent and no absolute values were given for the expression
levels of MMPs in relation to a house keeping gene. In a
further study on in vivo disc degeneration analysis, Cs-
Szabo et al. [7] used quantitative RT-PCR to analyze pro-
teoglycan mRNA changes in disc tissue samples. However,
no morphological correlation was performed so that only
very limited information was available on that issue.
With the present study, we were able to show that the
individual values for the various MMPs differed signifi-
cantly from sample to sample. However, there was a clear
tendency showing that expression of distinct MMPs was
significantly higher than others. This holds particularly true
for MMP-3 which was dramatically up-regulated in all
samples analyzed. On the contrary, MMP-7 and -9 were
only moderately elevated in few samples. The remaining
MMPs tested were intermediate with significant differences
between samples and various MMPs from case to case.
Furthermore, the two TIMPs tested similarly revealed an
up-regulation which was more pronounced for TIMP-1
than for TIMP-2. These observations clearly demonstrate
(and partly confirm) that
• MMPs and TIMPs are up-regulated in disc tissue
samples with signs of disc degeneration;
• there is a correlation between histological disc dege-
neration and the expression of isolated MMPs, particu-
larly MMP-3;
• there is evidence for the biologic activity of MMP-2
and -9 as shown by the enhanced gelatinolytic activity
during in situ zymography.
In order to test whether findings on the mRNA level
can be confirmed on the protein level, we used an
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immunohistochemical approach for the most relevant
MMPs. As the size of the tissue samples is very limited,
staining with specific antibodies was chosen, rather than
analysis of protein extracts via immunoblotting. Even
though data could only be evaluated in a semi-quantita-
tive manner, results on the protein level confirmed the
extensive expression of various MMPs seen on the gene
expression level. Again, MMP-3 was most extensively
expressed, while the other MMPs revealed less extensive
staining. A direct comparison on an individual basis was
not performed since the (dynamic) transcriptional
expression levels cannot directly be compared to the
(static) immunohistochemical protein data. Furthermore,
mRNA levels could be quantified numerically, while
immunohistochemical stainings were evaluated by a
morphometric approach. Nevertheless, our data clearly
support the particular role of MMP-3 on various expres-
sion levels.
Our study identified major MMPs using disc material
from symptomatic individuals with back pain. This is
corroborated by the findings on two samples from acute
trauma victims without histological evidence for relevant
age-related disc alterations. In these samples, the
expression levels for all MMPs were either not detectable
or very low. This confirms that in symptomatic indivi-
duals a ‘‘veritable’’ increase in enzyme synthesis is
present. However, since it is extremely difficult to obtain
‘‘normal’’ control material, the comparison between
‘‘normal’’ and ‘‘pathological’’ or ‘‘symptomatic’’ must be
performed very cautiously. Despite this fact, we provide
clear evidence that MMP-3 plays a central role during
disc tissue degradation. In addition, MMP-8 is similarly
up-regulated, showing a more consistent increase in the
values than other MMPs. These data clearly identify few
MMPs to be more involved in disc degradation than
others. In addition, the immunohistochemical and in situ
zymographic investigations clearly confirm these notions
although there are some differences in the extent and
level of expression between the transcriptional and the
protein (and activity) levels. These differences, however,
may be due to the fact that additional modulations, such
as protein secretion and enzyme degradation, may inter-
fere with the protein and activity data.
It is well known that MMPs possess different pH
optima, even though exact values do not exist for all
families and their members. However, it is known that
MMP-3, compared to most other MMPs, shows a rather
narrow pH window, with its optimum being around pH
5.5–6.5 [11], indicating that MMP-3 is particularly active
under microenvironmental conditions that can be found
during disc degeneration. Taking into consideration
that many other MMPs possess significantly higher pH
optima, e.g. pH 8.5 for MMP-2 [27], it becomes evident
why these enzymes may not play a pivotal role during
disc degeneration where pH levels are known to drop as
low as pH 5.7.
Our data fits very well with that obtained in an in vitro
model of disc cell alteration that mimics in vitro disc
degeneration [12]. In those experiments, high levels of
MMP-3 and -7 had been observed to be expressed in
herniated disc material with MMP-3 leading to resorption
of the disc material. It was furthermore shown that disc
cells were stimulated by macrophages to produce signi-
ficantly more MMP-3 than in the unstimulated situation.
In turn, it was assumed that MMP-3 may act as a mac-
rophage chemo-attractant. The application of recombinant
MMP-3 leads to enhanced resorption processes [14],
which is similar to that observed in vivo. Haro et al. [14]
described TNF-a as a major inducer of MMP-3. Similarly,
the generation of soluble TNF-a was essential for the
induction of MMP-3 in disc co-cultures [13] which in turn
was necessary to attract macrophage infiltration into
herniated disc material. We have recently shown that
TNF-a is also considerably expressed in degenerated non-
herniated disc tissue [35]. We hypothesize that intradiscal
activation of the TNF-a-cytokine network may be
involved not only in mediating discogenic pain but also
in stimulating a MMP-mediated cascade, leading to
progressive tissue destruction.
We also provide quantitative data for the up-regulation
of major endogenous MMP inhibitors, i.e. TIMPs-1 and -2,
which are differently expressed between various samples.
In general, the expression levels of TIMP-1 were higher
than that of TIMP-2. Although we have as yet no data on
the biological role of this up-regulation, we suggest that a
dysbalance between MMPs and TIMPs may have an
impact on the maintenance of the extracellular matrix. This
is well in line with other previous observations which had
included TIMP-3 as well [16].
Clinical relevance
In the present paper, we first provide (semi-)quantitative
data on the gene and protein level, indicating an up-regu-
lation of MMP-3 and -8 in clinical disc samples with a
significant correlation to histo-morphologic matrix
destruction. The central role of MMP-3 activation during
disc degeneration deserves further intense study. With
increasing knowledge, these MMPs may come into focus
of a therapeutic approach that treats or at least slows down
the degenerative cascade leading to low back pain.
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